Skip to main content

Table 2 Reconstitution and administration of omalizumab.

From: Omalizumab: Practical considerations regarding the risk of anaphylaxis

Step 1:

Draw 1.4 mL of SWFI, USP into a 3-cc syringe equipped with a 2.5 cm, 18 gauge needle.

Step 2:

Place the vial upright on a flat surface and using standard aseptic technique, insert the needle and inject the SWFI, USP directly onto the product.

Step 3:

Keeping the vial upright, gently swirl the upright vial for approximately 1 minute to evenly wet the powder. Do not shake.

Step 4:

After completing Step 3, gently swirl the vial for 5-10 seconds approximately every 5 minutes in order to dissolve any remaining solids. There should be no visible gel like particles in the solution. Do not use if foreign particles are present.*

Step 5:

Invert the vial for 15 seconds in order to allow the solution to drain toward the stopper. Using a new 3-cc syringe equipped with a 2.5 cm, 18 gauge needle, insert the needle into the inverted vial. Position the needle tip at the very bottom of the solution in the vial stopper when drawing the solution into the syringe. Before removing the needle from the vial, pull the plunger all the way back to the end of the syringe barrel in order to remove all of the solution from the inverted vial.

Step 6:

Replace the 18 gauge needle with a 25 gauge needle for subcutaneous injection.

Step 7:

Expel air, large bubbles, and any excess solution in order to obtain the required 1.2 mL dose. A thin layer of small bubbles may remain at the top of the solution in the syringe. Because the solution is slightly viscous, the injection may take 5 to 10 seconds to administer.

  1. * Some vials may take longer than 20 minutes to dissolve completely. If this is the case, repeat Step 4 until there are no visible gel like particles in the solution. It is acceptable to have small bubbles or foam around the edge of the vial. Do not use if the contents of the vial do not dissolve completely by 40 minutes.